Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

Journal of Clinical Psychopharmacology

Volumn 21, Issue 5, 2001, Pages 479-483

  Potkin, Steven G ^a,b   Fleming, Kirsten ^a   Jin, Yi ^a   Gulasekaram, Bala ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Psychiatry and Human Behavior ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RATING SCALE; SCHIZOPHRENIA; SPEECH; TASK PERFORMANCE; TREATMENT OUTCOME; VERBAL MEMORY;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COGNITION; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; WECHSLER SCALES;

EID: 0034785861     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200110000-00004     Document Type: Article

References (32)

1. Intelligence in schizophrenia: Meta-analysis of the research
2. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia
3. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
4. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
5. The mechanism of action of novel antipsychotic drugs
6. Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies
7. Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia
8. Neuroleptics: Effects on neuropsychological function in chronic schizophrenic patients
9. The effect of neuroleptics on cognitive and psychomotor function
10. Relationships between medication treatments and neuropsychological test performance in schizophrenia
11. Antipsychotic medication effects on neuropsychological functions
12. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenia inpatients
13. Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine
14. Effects of clozapine on cognitive function in schizophrenia
15. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
16. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia
17. The brief psychiatric rating scale
18. Negative symptoms in schizophrenia: Definition and reliability
19. Validity of the trail making test as an indication of organic brain damage
20. Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia
21. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4
22. Clozapine effects on glucose metabolic rate in striatum and frontal cortex
23. Neuropsychological predictors of skills training for chronic patients
24. What are the functional consequences of neurocognitive deficits in schizophrenia
25. Anticholinergic effects on memory: Benztropine versus amantadine
26. Memory deficits and anticholinergic levels in chronic schizophrenia
27. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients
28. D1 dopamine receptors in prefrontal cortex: Involvement in working memory